Yahoo Web Search

Search results

    • Is CRISPR Therapeutics Stock a Buy?

      Is CRISPR Therapeutics Stock a Buy?

      Motley Fool via Yahoo Finance· 9 hours ago

      CRISPR Therapeutics (NASDAQ: CRSP) is a star in the gene-editing therapy niche. The company made tremendous progress over the past few years, culminating...

    • Gene editing improves soybean yield

      China Daily· 3 days ago

      Chinese researchers have developed new soybean breeding lines using gene editing, potentially boosting the yield and protein content of the critical crop. Scientists used ...